NCT06181656View on ClinicalTrials.gov

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

RecruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

February 5, 2024

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Pneumococcal VaccineEsophageal CancerLymphopeniaChemoradiation
Interventions
BIOLOGICAL

Pneumonia vaccine

Given by SC

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER